Articles
Page 21 of 25
-
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P80
-
Genes involved in pulmonary hypertension of mice with endothelial-specific ablation of guanylyl cyclase A
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P77 -
Analysis of cGMP signalling with transgenic mice expressing FRET-based cGMP sensors
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P76 -
The soluble guanylate cyclase activator BAY 58-2667 protects against morbidity and mortality in endotoxic shock by recoupling organ systems
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P75 -
Endothelial GC-A can be a therapeutic target for metabolic syndrome
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P73 -
Receptor guanylyl cyclase B-mediated cGMP signalling controls axon bifurcation of cranial sensory ganglion neurons at the embryonic hindbrain
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P71 -
Differential regulation of platelet inhibition by cGMP- and cAMP-dependent protein kinases
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P69 -
Cardiac cGMP/cGMP-dependent protein kinase I signalling requires cysteine-rich LIM-only protein 4 (CRP4) to oppose angiotensin II induced hypertrophy and fibrosis
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P68 -
Krait natriuretic peptide (KNP): a non-classical NP
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P67 -
Discovery of neuroprotective soluble guanylate cyclase modulators (GCMs) aciting via NO/GC/cGMP/CREB pathway
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P65 -
Fishing for elusive cCMP-degrading phosphodiesterases
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P62 -
Potent inhibition of nitroglycerin bioactivation by diphenyleneiodonium (DIP)
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P49 -
Video microscopy as a tool to visualize cGMP effects on contractility and sperm transport in seminiferous tubules and the epididymal duct
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P44 -
Alternative splicing of α1 and β1 sGC genes is altered in aortic disease
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P42 -
Evidence for functional coupling of cGMP/cGKI signalling and TRPC channels in endothelium but not in vascular smooth muscle
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P40 -
Differential effects of PDE5 inhibitors on cardiac dysfunction in the MDX ouse model of Duchenne muscular dystrophy
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O38 -
A biodegradable in-situ polymer precipitation delivery system for sustained delivery of a novel chimeric natriuretic peptide CD-NP in an experimental model of myocardial infarction
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P38 -
Pseudomonas aeruginosaExoY, a cyclic GMP- and cyclic UMP-generating nucleotidyl cyclase
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O36 -
Increases survival by apo-sGC activation via post-stroke blood brain barrier stabilisation and anti-inflammation
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P36 -
Dual actions of ANP on endothelial permeability
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O35 -
Interstitial cells of Cajal plasticity rather than regeneration restores slow-wave activity and enteric neurotransmission upon acute damage
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P34 -
A novel physiological significance of natriuretic peptides in cancer metastasis
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O34 -
Crystal structures of the carboxyl cGMP binding domain of plasmodium falciparumcGMP-dependent protein kinase reveals a novel salt bridge crucial for activation
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P33 -
NO-H2S interactions involve cGMP
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O32 -
Phosphodiesterase 5 is main regulator of brown adipocyte differentiation
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P32 -
Cyclic GMP-mediated intercellular communication in mammalian ovarian follicles
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P31 -
Interstitial cells of Cajal link excitatory and nitrergic inhibitory neurotransmission with slow-wave activity in the intestine
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O30 -
Chronic activation of heme free soluble guanylate cyclase leads to cardio-renal protection in experimental hypertension
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P30 -
GUCY2C at the intersection of obesity and colorectal cancer
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O28 -
The role of VASP in cGMP-mediated vascular smooth muscle relaxation
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P28 -
Non-genomic thyroid hormone signaling through NO/cGMP/PKGII
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O26 -
Natriuretic peptides and fat metabolism
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O24 -
Effects of age and gender on the pharmacokinetics of the soluble guanylate cyclase stimulator riociguat
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P23 -
Chronic beta-adrenergic blockade prevents volume overload-induced re-localization and oxidation of soluble guanylyl cyclase
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O22 -
Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with renal impairment
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P22 -
Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with hepatic impairment
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P21 -
Structures of human PKG reveal cGMP-selectived activation mechanisms
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O16 -
Soluble guanylate cyclase crystal clear: 1stcrystal structure of the wild-type human heterodimeric sGC catalytic domains and implications for activity
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O14 -
Receptor guanylyl cyclase-G is a novel thermosensor in Grueneberg ganglion neurons involved in coolness-induced ultrasonic distress calls in mice
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P14 -
Identification and quantitation of 2´,3´-cGMP in murine tissues
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P12 -
G-protein signaling modulator 1 is a modifier of sGC-dependent vascular response
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P11 -
Pulmonary vascular adaptation to high-altitude living
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O9 -
Absorption behavior of riociguat: bioavailability, food effects, and dose-proportionality
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P7 -
Genetic variants of ANP and cardiometabolic protection: from populations to novel therapeutics
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O7 -
Effects of omeprazole and AlOH/MgOH on riociguat absorption
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P6 -
Pharmacokinetic interaction of ketoconazole, clarithromycin, and midazolam with riociguat
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P5 -
Effect of nitrite treatment on endothelial nitric oxide synthase in human left ventricle biopsy
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P3 -
Hydroxyurea reduces leukocyte interactions with the vessel wall in a haemolytic mouse model via a possible NO/cGMP-mediated effect
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P2 -
Increased nitrosative/oxidative stress lowers myocardial protein kinase G activity in heart failure with preserved ejection fraction
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O2 -
Neutral endopeptidase inhibitors SOL-1 and candoxatril counteract kidney fibrosis by reducing myofibroblast formation in mouse UUO model
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P1
Annual Journal Metrics
-
2022 Citation Impact
2.9 - 2-year Impact Factor
2.9 - 5-year Impact Factor
0.932 - SNIP (Source Normalized Impact per Paper)
0.603 - SJR (SCImago Journal Rank)2023 Speed
57 days submission to first editorial decision for all manuscripts (Median)
178 days submission to accept (Median)2023 Usage
790,731 downloads
400 Altmetric mentions
Peer-review Terminology
-
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication